HIF2α behaves as a pro-oncogenic effector in the regulation of erythropoietin, tumor angiogenesis, enhancement of pentose phosphate pathways, resistance to oxidative damage, endoplasmic reticulum stress, and tumor metastasis [30]. This evidence concerns the gene EPO and neoplasm.